4.57

14.70% 0.59

Adial Pharmaceuticals Inc (ADIL)

Overview News Price History Financials Why ADIL Down? Discussions Forecast Stock Split

Adial Pharmaceuticals Inc stock is traded at $4.57, with a volume of 70,664. It is up +14.70% in the last 24 hours and up +63.04% over the past month. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Previous Close:

$3.98

Open:

$3.84

24h Volume:

70,664

Relative Volume:

0.16

Market Cap:

$11.90M

Revenue:

Net Income/Loss:

$-7.77M

P/E Ratio:

-0.4614

EPS:

-9.9046

Net Cash Flow:

$-6.52M

1W Performance:

+8.43%

1M Performance:

+63.04%

6M Performance:

+69.07%

1Y Performance:

-53.65%

1-Day Range:

$3.84

$4.65

1-Week Range:

$3.84

$4.65

52-Week Range:

$1.31

$10.75

Adial Pharmaceuticals Inc Stock (ADIL) Company Profile

Name

Adial Pharmaceuticals Inc

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

434-422-9800

Address

1180 SEMINOLE TRAIL, CHARLOTTESVILLE, VA

Employee

Twitter

@AdialPharma

Next Earnings Date

2026-08-12

Latest SEC Filings

ADIL's Discussions on Twitter

Compare ADIL vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ADIL Adial Pharmaceuticals Inc	4.53	10.45M	0	-7.77M	-6.52M	-9.9046
VRTX Vertex Pharmaceuticals Inc	515.89	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	806.79	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	992.63	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	215.22	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.16	39.31B	5.76B	514.49M	1.10B	4.4813

Adial Pharmaceuticals Inc Stock (ADIL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-24	Initiated	Rodman & Renshaw	Buy
Oct-30-18	Initiated	Maxim Group	Buy
Oct-11-18	Initiated	Dawson James	Buy

Adial Pharmaceuticals Inc Stock (ADIL) Latest News

10:54 AM

Adial Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet

10:54 AM

10:19 AM

Adial Closes $32M Tranche of $64M Financing for Ulcerative Colitis Drug Development - Minichart

10:19 AM

07:58 AM

Form 8K Adial Pharmaceuticals Inc For: 17 August By Investing.com - Investing.com UK

07:58 AM

07:27 AM

Weekly Recap: Cash shortfall, warrant reliance and CEO succession, CFO exit - TradingView

07:27 AM

07:20 AM

Adial Reports $52 Million Second-Quarter Net Loss After Azora Acquisition - Quiver Quantitative

07:20 AM

07:15 AM

Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update - The Manila Times

07:15 AM

07:00 AM

A $46.2M Noncash Charge Hit Adial’s Latest Quarter—Why? - Stock Titan

07:00 AM

Aug 14, 2026

Adial Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2026

Adial Pharmaceuticals (NASDAQ: ADIL) lifts cash to $28.7M but flags going‑concern risk - Stock Titan

Aug 14, 2026

Aug 13, 2026

Form 8K Adial Pharmaceuticals Inc For: 13 August By Investing.com - Investing.com Nigeria

Aug 13, 2026

Adial Pharmaceuticals plans leadership changes tied to annual meeting vote - Investing.com

Aug 13, 2026

Adial Pharmaceuticals Plans Major Leadership and Board Transition - TipRanks

Aug 13, 2026

Adial PharmaceuticalsAs Of Aug 10, Anticipates Termination Of CEO Cary Claiborne After 2026 Annual Meeting - TradingView

Aug 13, 2026

Aug 12, 2026